AAV Production Everywhere: A Simple, Fast, and Reliable Protocol for In‐house AAV Vector Production Based on Chloroform Extraction
Current Protocols in Neuroscience · 2020-09 · 93 (1)
DOI: 10.1002/cpns.103 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Current Protocols in Neuroscience, online erschienen am 31.08.2020. Verfasst von Matilde Negrini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Behavioural Neuroscience Laboratory, Department of Experimental Medical Sciences, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Crafoordska Stiftelsen.
Abstract (Originalsprache)
Recombinant adeno‐associated virus (rAAV) is a mammalian virus that has been altered to be used as a gene delivery vehicle. Several changes to the viral genome have made them replication deficient so that this aspect of the viral infection cycle is under full control of the experimenter, while maintaining gene expression machinery. Over the last decades, rAAVs have become the gold standard for studying in vivo gene function and are especially favorable for gene transfer in the central nervous system. AAVs have been proven safe and provide stable gene expression over a long period of time. They are extensively used in preclinical experiments and show great potential for clinical applications. However, the use of AAVs in preclinical settings are often held back due to availability. Waiting lines are long at commercial production facilities, and in‐lab production is hindered due to lack of specific laboratory equipment needed. Here we present a novel production method that can be carried out in any molecular biology laboratory using standard laboratory equipment. We provide a simple, fast, and streamlined protocol for production that can result in titers comparable with the more time‐consuming iodixanol gradient ultracentrifugation method. The yield using this protocol is high enough for any type of study where AAV is the vector of choice. © 2020 The Authors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Behavioural Neuroscience Laboratory, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.
- Molecular Neuromodulation, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.
Förderung
- Crafoordska Stiftelsen
Zitieren
APA
Negrini, M., Wang, G., Heuer, A., Björklund, T., & Davidsson, M. (2020). AAV Production Everywhere: A Simple, Fast, and Reliable Protocol for In‐house AAV Vector Production Based on Chloroform Extraction. Current Protocols in Neuroscience, 93(1). https://doi.org/10.1002/cpns.103
Vancouver
Negrini M, Wang G, Heuer A, Björklund T, Davidsson M. AAV Production Everywhere: A Simple, Fast, and Reliable Protocol for In‐house AAV Vector Production Based on Chloroform Extraction. Current Protocols in Neuroscience. 2020;93(1). doi:10.1002/cpns.103
BibTeX
@article{Negrini2020,
author = {Negrini, Matilde and Wang, Gang and Heuer, Andreas and Björklund, Tomas and Davidsson, Marcus},
title = {AAV Production Everywhere: A Simple, Fast, and Reliable Protocol for In‐house AAV Vector Production Based on Chloroform Extraction},
journal = {Current Protocols in Neuroscience},
year = {2020},
volume = {93},
number = {1},
doi = {10.1002/cpns.103}
}
EUVIMED